Home › Peanut Hypersensitivity › North Carolina
Peanut Hypersensitivity clinical trials in North Carolina
4 studies for Peanut Hypersensitivity are looking for participants at sites in North Carolina.
Cities in North Carolina
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07279467Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- University of North Carolina at Chapel Hill Clinical and Translational Research Center( CTRC), Chapel Hill
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811Safety of MOON101 for the Treatment of Peanut Allergy
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 1
Ages 4 to 55 · All sexes · Updated Jul 14, 2026 · NCT07580898From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.